A randomised, placebo-controlled study of RIPK1 inhibitor GSK2982772 in patients with active ulcerative colitis.
BMJ Open Gastroenterol
; 8(1)2021 08.
Article
in En
| MEDLINE
| ID: mdl-34389633
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Oxazepines
/
Colitis, Ulcerative
Type of study:
Clinical_trials
/
Guideline
/
Prognostic_studies
Limits:
Humans
Language:
En
Year:
2021
Type:
Article